Costas Demonacos

Costas Demonacos is a Senior Lecturer in Pharmacy at the University of Manchester. He holds a BSc in Pharmacy from Aristotle University of Thessaloniki (1983) and a PhD in Molecular Biology & Biochemistry from the National and Kapodistrian University of Athens (1994). His research focuses on exploiting endoplasmic reticulum stress, unfolded protein response signaling, and reactive oxygen species (ROS) in cancer, neurodegenerative, and autoimmune disease therapies. He also investigates cell cycle regulation, transcriptional co-factors, and nuclear-mitochondrial inter-genomic signaling in malignant transformation.

He collaborates with institutions globally, including Mahidol University (Thailand), Kindai University (Japan), and Tohoku University (Japan). His teaching portfolio includes Pharmaceutical Immunology, Cancer Biology and Therapy, Development of Research Skills, and Physiology & Pharmacology (cardiovascular/respiratory systems). Demonacos is a member of professional bodies such as the European Association for Cancer Research, The Biochemical Society, and the Royal Pharmaceutical Society. He serves on editorial boards for journals like the World Academy of Sciences Journal and Oncology Reports, and contributed to a dataset on miR-663a's role in cancer cell regulation via the CXCR4-p21 pathway (figshare, 2017).

• Received a grant as a lead recipient for the Pharmacy Education Network under the Advance HE Connect Network On-Boarding initiative (2019).
• Supervised 26 students (names not listed).
• Actively involved in research activities including peer-review and editorial work since 2011.

His work aligns with UN Sustainable Development Goals contributing to advancements in medical research and technology.